PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
21-Sep-2020 Immune Regulation Limited Raises £40.6 Million / $53.4 Million Series B Equity Financing B3C newswire
21-Sep-2020 MagForce AG Publishes Shareholder Letter MagForce AG
21-Sep-2020 Global Point-of-Care Testing (POCT) Devices Market| Top Key players: Abbott, Alere, Roche, Siemens, Abaxis, and Acon Laboratories Lexis Business Insights
21-Sep-2020 Relief and NeuroRx Announce Partnership for Global Commercialization of RLF-100(TM) and Selection of Commercial Partners Relief Therapeutics Holdings AG
21-Sep-2020 Relief and NeuroRx Announce Partnership for Global Commercialization of RLF-100(TM) and Selection of Commercial Partners Relief Therapeutics & NeuroRx
21-Sep-2020 Global Monoclonal Mouse Antibody Market| Top Key players: Roche, Johnson & Johnson, Merck, Novartis, AbbVie, Amgen, Pfizer, Bayer, Lilly, Bristol-Myers Squibb, GlaxoSmithKline, Biogen, AstraZeneca, Sanofi, Alexion Pharmaceuticals, and Seattle Genetics Lexis Business Insights
21-Sep-2020 Latest report: Global Neuropathy Pain Treatment Market| Pfizer, Depomed, Eli Lilly, Endo, Grünenthal Group, and Arbor Pharmaceuticals Lexis Business Insights
21-Sep-2020 Latest report: Global Venous Stents Market|Boston Scientific, Medtronic, Veniti, Cook Medical, Optimed Med, and C.R. Bard Lexis Business Insights
21-Sep-2020 Hyde Engineering + Consulting Announces New VP of Global Engineering Hyde Engineering + Consulting, Inc.
21-Sep-2020 Hyde Engineering + Consulting Announces New VP of Global Engineering Hyde Engineering + Consulting, Inc.
21-Sep-2020 Key Milestone: The first patient successfully dosed with the candidate drug SR419 for peripheral neuropathic pain Shanghai SIMR Biotech Co.,Ltd
21-Sep-2020 Innovent and Lilly Jointly Release Phase 3 Results of TYVYT® (Sintilimab Injection) in Combination with GEMZAR® (Gemcitabine) and Platinum Chemotherapy as First-Line Treatment for Squamous Non-Small Cell Lung Cancer at ESMO Virtual Congress 2020 Innovent Biologics, Inc.
20-Sep-2020 Verzenio® Significantly Reduced the Risk of Cancer Recurrence by 25% for People with HR+, HER2- High Risk Early Breast Cancer Eli Lilly and Company
20-Sep-2020 Verzenio® Significantly Reduced the Risk of Cancer Recurrence by 25% for People with HR+, HER2- High Risk Early Breast Cancer Eli Lilly and Company
20-Sep-2020 Clinical Data From Full Phase 1 Cohort Of Investigational Sotorasib Published In New England Journal Of Medicine Amgen
20-Sep-2020 Janssen Presents Findings from Global, Multi-Center Trial Examining Amivantamab in Combination with Lazertinib in Patients with EGFR-Mutated Non-Small Cell Lung Cancer The Janssen Pharmaceutical Companies of Johnson & Johnson
20-Sep-2020 Blueprint Medicines Reports ARROW Trial Data at ESMO Virtual Congress 2020 Demonstrating Durable Clinical Benefits of GAVRETO(TM) (Pralsetinib) in Patients with Advanced RET-Mutant Medullary Thyroid Cancer Blueprint Medicines Corporation
19-Sep-2020 Oculoplastic Surgery Market: Comprehensive Analysis Of The Current Trends And Inclinations, Along With The Future 2027 | Emerging Players – Zimmer Biomet, B. Braun Melsungen AG, Integra LifeSciences Corporation CDN Newswire
19-Sep-2020 Virtual Reality (VR) HEALTH Market : Industry Share, Growth, Trends, Revenue Analysis To 2027 | Top Companies- Vicarious Surgical Siemens Healthcare Private Limited, Virtalis LTD. CDN Newswire
19-Sep-2020 Rare Disease Genetic Testing Market : Size, Share, Industry Trends To 2027 | Leading Players- Quest Diagnostics, Centogene N.V., Eurofins Scientific, Strand Life Sciences CDN Newswire